Ledger.Open graph →
SEC Form D · filed August 21, 2019

Hoth Therapeutics, Inc

Offering
$5.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Mark Nottoli · Boulder, CODirectorTimothy Bovard · New Orleans, LAExecRobert Grant · Denver, COExec · DirectorWendye J. Robbins · South San Francisco, CADirectorTroy Dayton · Boulder, CODirectorCole Winans · Denver, CODirectorSantiago D. Suarez Florez · USAQUEN, BOGATA, MauritiusDirectorChristopher D. Reid · USAQUEN, BOGATA, MauritiusExec · DirectorFelipe D. De La Vega Vargara · USAQUEN, BOGATA, MauritiusDirectorPromus Equity Partners, LLC · Chicago, ILDirectorIan M. Lawrence · Toronto, Ontario, CanadaDirectorSedef M. Koktenturk · LUXEMBOURG, LuxembourgExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗